6 month supply tirzepatide Tirz Initial Program – Months (New Patients) – $149/month | CoraDoc™ Tirzepatide Before and After Results:

Long-term cardiovascular outcome data from the SURPASS-CVOT trial are expected in 2025 to further establish safety and efficacy

Seek urgent medical advice if you experience: Severe or persistent abdominal pain , especially if accompanied by nausea and vomiting, as this may indicate pancreatitisa rare but serious adverse effect associated with GLP-1 receptor agonists

No video visit is required

Sterile water lacks this protection, requiring single-use or very short storage periods

Zepbound is FDA approved for weight loss and long-term maintenance in adults with obesity, or adults who are overweight and have at least one weight-related health condition, such as high blood pressure or high cholesterol